文献速递甲状腺疾病

碘对比剂给药后甲状腺功能障碍风险:一项前瞻性纵向队列分析

Thyroid Dysfunction Risk After Iodinated Contrast Media Administration: A Prospective Longitudinal Cohort Analysis.
PubMed 文献 · J Clin Endocrinol Metab · 2025-01-01

在美国退伍军人医疗系统开展前瞻性纵向队列,122例接受碘对比剂者中位年龄70.0岁、98.4%男性,中位随访18个月。碘诱导甲状腺功能障碍发生率为11.5%(14/122),其中甲状腺功能亢进症6例(4.9%)、亚临床甲状腺功能减退症8例(6.6%),末次随访时20例甲状腺功能障碍者中10例持续存在亚临床甲状腺功能异常。

要点

  • 碘对比剂后碘诱导甲状腺功能障碍发生率为11.5%(14/122),中位随访18个月。
  • 新发甲状腺功能亢进症6例(4.9%),其中1例为明显甲状腺功能亢进症。
  • 新发亚临床甲状腺功能减退症8例(6.6%),末次随访20例中10例持续异常。

核心结论

  • 即使在总体碘充足地区人群中,过量碘负荷对甲状腺功能障碍的长期风险仍少见,支持碘对比剂给药后开展针对性监测。

研究设计与样本

  • 前瞻性纵向队列研究,纳入美国退伍军人医疗系统接受碘对比剂的患者122例,中位年龄70.0岁(四分位距62.2-74.0岁),98.4%为男性。
  • 基线检测血清甲状腺功能、甲状腺抗体及炎症标志物,第1个月、第3个月及此后每6个月复查甲状腺功能直至36个月。
  • 采用混合效应模型评估甲状腺功能障碍风险及甲状腺激素水平的纵向变化。

主要发现

  • 基线时6例受试者在接受碘对比剂前已存在亚临床甲状腺功能障碍。
  • 中位随访18个月期间,碘诱导甲状腺功能障碍发生率为11.5%(14/122)。
  • 6例(4.9%)发生甲状腺功能亢进症(包括1例明显甲状腺功能亢进症),8例(6.6%)发生亚临床甲状腺功能减退症。
  • 末次随访时,20例甲状腺功能障碍者(14例新发和6例既往存在)中10例持续存在亚临床甲状腺功能亢进症或甲状腺功能减退症。
  • 整个队列纵向观察到甲状腺激素在参考范围内的细微变化。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Iodinated contrast media (ICM) is a common source of excess iodine in medical settings, given the common use of iodinated radiologic procedures. OBJECTIVE: To determine the long-term risks of thyroid dysfunction following iodinated contrast administration in a prospective study. METHODS: A longitudinal cohort study was conducted of patients in the United States Veterans Affairs medical system who received ICM. Serum thyroid function, thyroid antibody, and inflammatory markers were measured at baseline. Thyroid function tests were repeated at 1 month, 3 months, and every 6 months thereafter until 36 months. Risk of thyroid dysfunction and longitudinal changes in thyroid hormone levels were assessed using mixed effect models. RESULTS: There were 122 participants (median age, 70.0 [interquartile range 62.2-74.0] years; 98.4% male). At baseline, 6 subjects had subclinical thyroid dysfunction prior to ICM receipt. During median follow-up of 18 months, iodine-induced thyroid dysfunction was observed in 11.5% (14/122); 6 (4.9%) developed hyperthyroidism (including 1 with overt hyperthyroidism) and 8 (6.6%) subclinical hypothyroidism. At last follow-up, 10 of 20 subjects with thyroid dysfunction (14 new-onset cases and 6 with preexisting thyroid dysfunction) had persistent subclinical hyperthyroidism or hypothyroidism. There were also subtle changes in thyroid hormones observed longitudinally within the reference ranges in the overall cohort. CONCLUSION: There is a rare long-term risk of an excess iodine load on thyroid dysfunction even among individuals from an overall iodine-sufficient region, supporting the need for targeted monitoring following iodinated contrast administration.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Sohn SY, Inoue K, Bashir MT, et al. Thyroid Dysfunction Risk After Iodinated Contrast Media Administration: A Prospective Longitudinal Cohort Analysis. J Clin Endocrinol Metab. 2025. PMID: 38700099. doi:10.1210/clinem/dgae304

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。